2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Lymphoma
3
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Vomiting
1
Sarcoma, Alveolar Soft Part
1
Recurrence
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Nausea and Vomiting
1
Philadelphia Chromosome
1
Neuroendocrine Tumors
1
Neoplastic Cells, Circulating
1
Nausea
1
Metastatic Neuroendocrine Prostate Cancer
1
Medulloblastoma
1
Lymphoma, B-Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, B-Cell
1
Leukemia
1
Hematologic Neoplasms
1
Ependymoma
1
Colorectal Neoplasms
1
Chondrosarcoma
1
Carcinoma, Non-Small-Cell Lung
1
Burkitt Lymphoma
1
Bulbo-Spinal Atrophy, X-Linked
1
Advanced Solid Tumors
1
Interventions
bicalutamide
5
enzalutamide
4
exemestane
2
darolutamide
2
abiraterone
2
pembrolizumab
1
ostarine
1
nilutamide
1
cabazitaxel
1
apalutamide
1
abemaciclib
1
Vorinostat
1
Triptorelin Pamoate
1
Tamoxifen
1
Prophylactic Mastectomy
1
Prednisolone
1
Panobinostat
1
Mifepristone
1
Letrozole
1
Histamine H2 Antagonists
1
Histamine Antagonists
1
Goserelin
1
Doxorubicin
1
Docetaxel
1
Dasatinib
1
Cisplatin
1
CP protocol
1
Aromatase Inhibitors
1
Antiemetics
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Bulbo-Spinal Atrophy, X-Linked
×
Antiemetics
×
Clear all
NCT03050866
2021-08-20
CABA-V7
Erasmus Medical Center
Phase 2
Unknown
140 enrolled